Serenamin en es it fr

Serenamin Brand names, Serenamin Analogs

Serenamin Brand Names Mixture

  • No information avaliable

Serenamin Chemical_Formula


Serenamin RX_link

Serenamin fda sheet

Serenamin msds (material safety sheet)

Serenamin MSDS

Serenamin Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Serenamin Molecular Weight

284.74 g/mol

Serenamin Melting Point


Serenamin H2O Solubility

Slightly soluble (50 mg/L)

Serenamin State


Serenamin LogP


Serenamin Dosage Forms

Tablets; Injectable solution

Serenamin Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Serenamin Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Serenamin Absorption

Essentially complete, with a bioavailability of 93%.

Serenamin side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Serenamin Patient Information

Serenamin Organisms Affected

Humans and other mammals